Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  1996-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/11.6.1079PMID 8671972
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized controlled study of iron supplementation in patients treated with erythropoietin.

  1996cited by this paper
• R-HuEPO hyporesponsiveness--who and why?

  1995cited by this paper
• Chairman's Workshop Report R-HuEPO hyporesponsiveness—who and why?

  1995cited by this paper
• Intravenous iron-sucrose complex to reduce epoetin demand in dialysis patients.

  1994cited by this paper
• Structure/histotoxicity relationship of parenteral iron preparations.

  1992cited by this paper
• Detection of functional iron deficiency during erythropoietin treatment: a new approach.

  1992cited by this paper
• Disorders of iron metabolism. Diagnostic methods.

  1982cited by this paper

• Biochemical markers of iron status and iron accumulation in peritoneal dialysis patients treated with ferric citrate

  2023cites this paper
• Brief Review of Studies on Oral Martial Therapy Compared to the Administration of Intravenousiron in Nephrology and Dialysis

  2018cites this paper
• Efficacy of administration of oral liposomal iron after a period ofintravenous iron carboxymaltose in two groups of chronic kidney diseasepatients: home hemodialysis and conservative therapy

  2018cites this paper
• Diagnosing and preventing iron overload

  2017cites this paper
• Effect of intravenous iron on outcomes of acute kidney injury

  2016cites this paper
• Nutrition , Anaemia and Erythropoietin Therapy lain

  2016cites this paper
• Outcomes Associated with Conventional Accelerated Versus Once-Weekly IV Iron Therapy in Outpatients Undergoing Hemodialysis.

  2015cites this paper
• Cumulative iron dose and resistance to erythropoietin

  2015cites this paper
• A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients

  2015cites this paper
• Nutrition and Anemia in End-stage Renal Disease

  2013cites this paper
• Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis

  2013cites this paper
• Pharmacokinetics and Safety of Deferasirox in Subjects with Chronic Kidney Disease Undergoing Haemodialysis Running title : Deferasirox in chronic kidney disease

  2013cites this paper
• Management of Anemia on Hemodialysis

  2013cites this paper
• Hematologic Aspects of Kidney Disease

  2012cites this paper
• Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease

  2012cites this paper
• Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin.

  2011cites this paper
• Administration of the same dose of epoetin-beta intravenously and subcutaneously to patients with renal anaemia

  2011cites this paper
• Establishing maintenance doses of lV iron in anemia management to improve patient outcomes.

  2011cites this paper
• Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease.

  2011cites this paper
• Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy.

  2011cites this paper
• 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

  2010cites this paper
• A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients

  2010cites this paper
• Integrated Care of Anemia in Chronic Kidney Disease Patients: Concepts in Intravenous Iron Management: Part One

  2010cites this paper
• Diagnosis of iron deficiency in patients undergoing hemodialysis.

  2010cites this paper
• Can intravenous iron therapy meet the unmet needs created by the new restrictions on erythropoietic stimulating agents?

  2010cites this paper
• Hepcidin — a hepatic hormone that controls iron homeostasis

  2010cites this paper
• Erythropoietic stimulating agents

  2010cites this paper
• Low-Molecular-Weight Iron Dextran in the Management of Renal Anaemia in Patients on Haemodialysis – the IDIRA Study

  2009cites this paper
• Iron sequestration and anemia of inflammation.

  2009cites this paper
• Efficacy of low‐dose i.v. iron therapy in haemodialysis patients

  2009cites this paper
• PDpoietin in comparison with Eprex in treatment of anemic patients on hemodialysis.

  2009cites this paper
• Hemoglobin Control, ESA Resistance, and Regular Low‐Dose IV Iron Therapy: A Review of the Evidence

  2009cites this paper
• A comprehensive vision for intravenous iron therapy.

  2008cites this paper
• Chapter 67 – Iron and Erythropoietin-Related Therapies

  2008cites this paper
• rhEPO in surgical oncology

  2008cites this paper
• 2008年版 日本透析医学会「慢性腎臓病患者における腎性貧血治療のガイドライン」

  2008cites this paper
• Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.

  2008cites this paper
• IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.

  2008cites this paper
• The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?

  2008cites this paper
• The role of intravenous iron in anemia management and transfusion avoidance

  2008cites this paper
• La diagnosi di laboratorio della carenza di ferro

  2008cites this paper
• Economic considerations in a changing anemia environment.

  2008cites this paper
• Short‐term benefits and risks of intravenous iron: a systematic review and meta‐analysis

  2007cites this paper
• Angina pectoris and intensive intravenous iron treatment in hemodialysis patients.

  2007cites this paper
• Iron management in nondialysis-dependent CKD.

  2007cites this paper
• Erythropoietin and iron-restricted erythropoiesis.

  2007cites this paper
• NARRATIVE REVIEW Iron Management in Nondialysis-Dependent CKD

  2007cites this paper
• Chemical reactions of vitamin C with intravenous-iron formulations.

  2007cites this paper
• Improving Hemoglobin Response in Patients With Chemotherapy-Induced Anemia

  2007cites this paper
• Iron

  2006cites this paper
• iagnosis of Iron Deficiency n Hemodialysis Patients

  2006cites this paper
• Resolving the paradigm crisis in intravenous iron and erythropoietin management.

  2006cites this paper
• Biochemical Targets

  2006cites this paper
• Molecular pathogenesis of anemia of chronic disease

  2006cites this paper
• Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).

  2006cites this paper
• Iron supplementation in renal anemia.

  2006cites this paper
• HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Erythropoietin Resistance in the Treatment of the Anemia of Chronic Renal Failure

  2006cites this paper
• Sodium ferric gluconate complex maintenance therapy in children on hemodialysis

  2006cites this paper
• The CARI guidelines. Prevention of progression of kidney disease.

  2006cites this paper
• Drug Insight: safety of intravenous iron supplementation with sodium ferric gluconate complex

  2006cites this paper
• How Can Erythropoietin Requirements be Reduced in Dialysis Patients?

  2006cites this paper
• The Relevance of Iron in Erythropoietin-Stimulated Erythropoiesis

  2006cites this paper
• EFFECTS OF INTRAVENOUS ABT‐870 (IRON (III)‐HYDROXIDE OLIGOSACCHARIDE) ON MEAN ARTERIAL PRESSURE AND HEART RATE IN THE ANAESTHETIZED BEAGLE: COMPARISON WITH OTHER IRON‐CONTAINING HAEMATINIC AGENTS

  2005cites this paper
• Subcutaneous Compared With Intravenous Epoetin Treatment in Patients on Hemodialysis: One Center Study

  2005cites this paper
• Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients.

  2005cites this paper
• Intravenous iron therapy in pediatric hemodialysis patients: a meta-analysis

  2004cites this paper
• Impact of a pharmacist-implemented anemia management in outpatients with end-stage renal disease in Japan.

  2004cites this paper
• Ferrlecit ( sodium ferric gluconate complex in sucrose injection )

  2004cites this paper
• A Study of the Response of Elderly Patients with End-Stage Renal Disease to Epoetin Alfa or Beta

  2004cites this paper
• Iron therapy in the pediatric hemodialysis population

  2004cites this paper
• 2004 Japanese Society for Dialysis Therapy Guidelines for Renal Anemia in Chronic Hemodialysis Patients *

  2004cites this paper
• Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.

  2003cites this paper
• Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content

  2003cites this paper
• Achieving optimal patient outcomes with intravenous iron.

  2003cites this paper
• Intermittent versus maintenance iron therapy in children on hemodialysis: a randomized study

  2003cites this paper
• Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients.

  2002cites this paper
• Advances in anaemia management: Current evidence

  2002cites this paper
• Erythropoiesis, iron metabolism and iron supplementation during erythropoietin therapy

  2002cites this paper
• Renal anaemia in children: the role of the specialist nurse.

  2002cites this paper
• Iron administration and clinical outcomes in hemodialysis patients.

  2002cites this paper
• rHuEPO in surgical oncology

  2002cites this paper
• Intravenous iron treatment: a comparison of available drugs

  2002cites this paper
• Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

  2002cites this paper
• Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.

  2002cites this paper
• TOTAL DOSE INFUSION IRON DEXTRAN THERAPY IN PREDIALYSIS CHRONIC RENAL FAILURE PATIENTS

  2002cites this paper
• Nontransferrin‐bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion

  2002cites this paper
• Maintenance intravenous iron therapy in pediatric hemodialysis patients

  2001cites this paper
• Suspected iron dextran-related adverse drug events in hemodialysis patients.

  2001cites this paper
• Optimizing erythropoietin therapy in hemodialysis patients.

  2001cites this paper
• IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.

  2001cites this paper
• Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis.

  2001cites this paper
• Reduction of recombinant human erythropoietin maintenance dose by supplementation with a low-dose iron preparation, given intravenously

  2001cites this paper
• Unanticipated Favorable Effects of Correcting Iron Deficiency in Chronic Hemodialysis Patients

  2001cites this paper
• Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients

  2000cites this paper
• PRODUCT MONOGRAPH

  2000cites this paper
• Parenteral iron use in the management of anemia in end-stage renal disease patients.

  2000cites this paper
• The Comparative Safety of Intravenous Iron Dextran, Iron Saccharate, and Sodium Ferric Gluconate

  2000cites this paper
• Should the Hematocrit (Hemoglobin) Be Normalized in Pre-ESRD or Dialysis Patients? Yes!

  2000cites this paper
• Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients.

  2000cites this paper
• Erythropoietin, iron, and erythropoiesis.

  2000cites this paper